Article
Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction.
Thrombosis and haemostasis - 1 Oct 2012
Kurnik Daniel, Qasim Husam, Sominsky Sophie, Lubetsky Aharon, Markovits Noa, Li Chun, Stein C Michael, Halkin Hillel, Gak Eva, Loebstein Ronen
Abstract excerpt
Pharmacogenetic dosing algorithms help predict warfarin maintenance doses, but their predictive performance differs in different populations, possibly due to unsuspected population-specific genetic variants. The objectives of this study were to quantify the effect of the VKORC1 D36Y variant (a marker of warfarin resistance previously described in 4% of Ashkenazi Jews) on warfarin maintenance doses and to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
